Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Cancer|October 8, 2008
African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patientsManuel A Molina, Michael C Cheung, Eduardo A Perez, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 3, 2005
Pancreaticoduodenectomy in the presence of superior mesenteric venous obstructionLeonidas G Koniaris, Kevin F Staveley-O'Carroll, Herbert J Zeh, et al.Brachytherapy|June 4, 2023
CivaSheet® use for soft tissue sarcoma: A single institution experienceCrystal Seldon, Julie G Grossman, Gautam Shrivastava, et al.Breast Cancer Research and Treatment|June 14, 2022
Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstructionOrli Friedman-Eldar, Jonathan Burke, Iago de Castro Silva, et al.Japanese Journal of Clinical Oncology|August 21, 2007
Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancerBach Ardalan, Seth A Spector, Alan S Livingstone, et al.Annals of Surgical Oncology|November 6, 2002
Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patientsMohsen Shabahang, Dido Franceschi, Noriyo Yamashiki, et al.Surgery|March 4, 2022
Persistent and interdependent: Racial disparities and their mechanisms in postmastectomy breast reconstructionJonathan Burke, Orli Friedman-Eldar, Gili Halfteck, et al.Annals of Surgery|August 26, 2011
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?Leonidas G Koniaris, David M Levi, Felipe E Pedroso, et al.Cancer Research|August 29, 2014
Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinomaZhiqiang Wang, Thiago G Da Silva, Ke Jin, et al.Annals of Surgery|July 9, 2019
Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic CancerFrancis I Macedo, Emily Ryon, Shishir K Maithel, et al.Pageof 7